Sharps Technology, Inc. (STSS)

USD 1.97

(-4.37%)

Market Cap (In USD)

3.54 Million

Revenue (In USD)

-

Net Income (In USD)

-9.84 Million

Avg. Volume

2.93 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.7-18.15
PE
-
EPS
-
Beta Value
1.189
ISIN
US82003F1012
CUSIP
82003F101
CIK
1737995
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Robert M. Hayes
Employee Count
-
Website
https://sharpstechnology.com
Ipo Date
2022-04-14
Details
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.